Table 3.
Logistic regression model: adjusted ORs (95% CIs) of hyperglycemic patterns, in relation to the respective outcomes.
| Persistent Normoglycemia | Baseline Hyperglycemia | 24-h Hyperglycemia | Persistent Hyperglycemia | |
|---|---|---|---|---|
| Three-month poor outcome † | 1 | 0.99 (0.41–2.38) |
1.75 (0.54–5.67) |
6.89 (1.98–23.94) p = 0.002 |
| No major neurological improvement at discharge † | 1 | 3.37 (1.39–8.19) p = 0.007 |
3.41 (0.96–12.16) |
11.15 (2.99–41.52) p = 0.001 |
| In-hospital mortality † | 1 | 0.39 (0.07–2.12) |
2.67 (0.58–12.30) |
5.37 (1.61–17.96) p = 0.006 |
| Three-month mortality † | 1 | 0.50 (0.14–1.82) |
1.33 (0.31–5.66) |
4.43 (1.40–13.97) p = 0.01 |
| Presence of ICH ‡ | 1 | 1.15 (0.43–3.08) |
0.45 (0.08–2.44) |
6.89 (2.35–20.21) p = 0.001 |
| Presence of SICH ‡ | 1 | 1.25 (0.33–4.71) |
1.31 (0.21–8.31) |
5.42 (1.54–19.15) p = 0.009 |
ICH: intracranial hemorrhage; SICH: symptomatic intracranial hemorrhage. † Adjusted for age, HbA1c values, use of antidiabetic drugs, intravenous thrombolysis, baseline NIHSS score, pre-stroke mRS, time from symptom onset to endovascular treatment, and successful recanalization. ‡ Adjusted for age, HbA1c values, use of antidiabetic drugs, intravenous thrombolysis, baseline NIHSS score, pre-stroke mRS, time from symptom onset to endovascular treatment, successful recanalization, and systolic blood pressure > 180 mmHg.